PHARMACIELO LTD (PCLO.CA) Stock Earnings & Estimates
Canada - TSX Venture Exchange - TSX-V:PCLO - CA71716K1012 - Common Stock
0.095 CAD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 5.309M 172.93% | 1.542M -70.96% | 3.967M 157.28% | |
| EBITDA YoY % growth | -8.948M 60.59% | -9.142M -2.17% | -4.156M 54.54% | |
| EBIT YoY % growth | -10.527M 56.06% | -10.556M -0.28% | -5.798M 45.07% | |
| Operating Margin | -198.30% | -684.67% | -146.17% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.06 -20.00% | -0.03 | -0.03 | -98.02% |
| Q2 2021 Q2Q % growth | -0.04 42.86% | -0.03 | -0.01 | -32.01% |
| Q1 2021 Q2Q % growth | -0.05 28.43% | 0.05 | -0.10 | -199.01% |
| Q4 2020 Q2Q % growth | -0.16 | 0.02 | -0.18 | -892.08% |
| Q3 2020 Q2Q % growth | -0.05 | 0.01 | -0.06 | -595.05% |
| Q2 2020 Q2Q % growth | -0.07 | -0.04 | -0.03 | -73.27% |
| Q1 2020 Q2Q % growth | -0.07 | -0.10 | 0.03 | 30.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2026 Q2Q % growth | 889K -33.10% | % | ||
| Q1 2026 Q2Q % growth | 322.5K -58.85% | % | ||
| Q4 2025 Q2Q % growth | 486.9K 102.62% | % | ||
| Q3 2025 Q2Q % growth | 1.127M 361.89% | % | ||
| Q2 2025 Q2Q % growth | 1.329M 277.85% | % | ||
| Q1 2025 Q2Q % growth | 783.7K 391.35% | % | ||
| Q4 2024 Q2Q % growth | 240.3K -69.45% | % | ||
| Q3 2024 Q2Q % growth | 244K -83.88% | % | ||
| Q2 2024 Q2Q % growth | 351.7K -26.00% | % | ||
| Q1 2024 Q2Q % growth | 159.5K -95.20% | % | ||
| Q4 2023 Q2Q % growth | 786.5K -34.52% | % | ||
| Q3 2023 Q2Q % growth | 1.513M 346.90% | % | ||
| Q2 2023 Q2Q % growth | 475.3K -2.04% | % | ||
| Q1 2023 Q2Q % growth | 3.32M 644.39% | % | ||
| Q4 2022 Q2Q % growth | 1.201M 77.88% | % | ||
| Q3 2022 Q2Q % growth | 338.6K -61.57% | % | ||
| Q2 2022 Q2Q % growth | 485.2K 1,773.36% | % | ||
| Q1 2022 Q2Q % growth | 446K -74.47% | % | ||
| Q4 2021 Q2Q % growth | 675.3K 31.28% | % | ||
| Q3 2021 Q2Q % growth | 881.1K 34.15% | 529.24K | 351.86K | 66.48% |
| Q2 2021 Q2Q % growth | 25.9K -80.09% | 678.72K | -652.82K | -96.18% |
| Q1 2021 Q2Q % growth | 1.747M | 6.56M | -4.813M | -73.37% |
| Q4 2020 Q2Q % growth | 514.4K | 2.066M | -1.552M | -75.10% |
| Q3 2020 Q2Q % growth | 656.8K | 1.608M | -951.2K | -59.15% |
| Q2 2020 Q2Q % growth | 130.1K | 141.4K | -11.3K | -7.99% |
| Q1 2020 Q2Q % growth | 707.01K | -707.01K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |